Maya will be the outcomes data capture platform for veterans undergoing psychedelic treatments funded by Heroic Hearts Project. Maya will simultaneously be deployed with related organizations, The Mission Within, Heroic Path to Light, and The Hope Project. Combined, this partnership will generate the largest structured dataset illustrating health outcomes of psychedelic treatments for veterans and their family members.

Follows a successful pilot study at Children's Hospital of Richmond at VCU for post-surgical monitoring of patients at home

Category One Inc. and HealthLinx Join Forces to Drive Elite Healthcare Outcomes

93 Percent of Warriors Positively Impacted through Community Integration Support

Following a Successful Hackathon, National Philanthropic Organization Looks to Act on Insights Revealed In Valuable Data

Healthcare has often looked at education as "non-productive time that should be limited or eliminated if at all possible". By adopting a different set of core principles, education can be turned into learning that delivers measurable changes in patient outcomes:
1. Everything is about our patient(s)
2. Education ≠ learning
3. Learning = changed outcomes
4. Learning is an expertise (that should be consulted by content experts)
5. Everyone is in Learning

Richard Nordstrom, CEO, Liberate Ideas Inc., joined other healthcare and life science leaders - including Ernst & Young, Sanofi, Pfizer and patient advocacy organizations - to discuss ways to move the health care industry forward "from patient adherence to patient centricity." Insights from this 2015 EY New Jersey Life Science and Healthcare Summit, held earlier this summer were just released.

Pharmacogenomics or pharmacogenetic testing is a science that can be used to test individual responses to drugs, thereby avoiding medical malpractice claims. Either of the synonymous terms refers to the study of the genetic variations in metabolic pathways in the body -.

Two-part Webinar series to focus on methodological and measures set recommendations of the DMAA Outcomes Guidelines Report, the industry consensus, evidence-based approach to measuring clinical and financial outcomes in population health management.